| Autor: |
Janiszewska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL, USA., Tabassum DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Research Square, Durham, NC, USA., Castaño Z; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Cristea S; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Yamamoto KN; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA., Kingston NL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Murphy KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Harper NW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Del Alcazar CG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Alečković M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Ekram MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; WuXi NextCODE, Cambridge, MA, USA., Cohen O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Kwak M; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Qin Y; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; EdiGene, Cambridge, MA, USA., Laszewski T; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Luoma A; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Marusyk A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Department of Cancer Imaging and Metabolism, Moffitt Cancer Center, Tampa, FL, USA., Wucherpfennig KW; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, and Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA, USA., Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA., Fan R; Department of Biomedical Engineering, Yale School of Medicine, New Haven, CT, USA.; Yale Comprehensive Cancer Center, New Haven, CT, USA., Michor F; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., McAllister SS; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Harvard Stem Cell Institute, Cambridge, MA, USA., Polyak K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute of Harvard and MIT, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Ludwig Center at Harvard, Boston, MA, USA. kornelia_polyak@dfci.harvard.edu.; Harvard Stem Cell Institute, Cambridge, MA, USA. kornelia_polyak@dfci.harvard.edu. |
Full text from SpringerLink